In the News / Politics

Tasimelteon (Hetlioz®): First FDA Approved Pharmacologic Agent for Treatment of Non-24 in Completely Blind Individuals

By: Beatrisa Popovitz, Senior Staff Editor - On January 31st 2014, the FDA announced the release of a revolutionary new…

12 years ago

New Legislation Redefines Oversight for Compounding Pharmacies

By: Davidta Brown, Senior Staff Editor - As the world of healthcare and its provision evolves, laws which organize and…

12 years ago

Prior Experience and the Growth of the Biosimilars Market

By: Davidta Brown, Senior Staff Editor - In 21st century medicine, pharmaceuticals have come to include compounds derived through novel…

12 years ago

The Status of Surveillance of Japanese Encephalitis in Asia

By: Sabrina Ahmed, PharmD Candidate c/o 2017 - One recent stride towards combating worldwide infectious disease has been in the…

12 years ago

Methadone Associated Arrhythmias on the Rise

By: Jenny Park, PharmD Candidate c/o 2015 - Methadone maintenance therapy is prescribed for opioid dependency. Many HIV patients who…

12 years ago

A Brave New World for Lipid Management

By: Amrita Singh, PharmD Candidate c/o 2015 - Last November, the American College of Cardiology and the American Heart Association…

12 years ago

The Increasing Roles of Pharmacists in Transplant Outcomes

By: Jenny Park, PharmD Candidate c/o 2015 - Medication adherence is a big part of a patient’s success in managing…

12 years ago

Dengue Fever: Where Do We Go From Here?

By: Sherin Pathickal, PharmD Candidate c/o 2016 - Dengue Fever, widely known as “break-bone fever,” is an illness that causes…

12 years ago

New Alternative First Line Therapy for EGFR NSCLC

By: Jenny Park, PharmD Candidate c/o 2015 - On July 12, 2013, the FDA approved afatinib (GilotrifTM) as a new…

12 years ago

Say Hello to JNC8: New Hypertension Guidelines

By: Frances Trosa PharmD Candidate c/o 2015 - After much anticipation, the report from the Eighth Joint National Committee (JNC…

12 years ago